文献速递慢性肾脏病肾血管病与高血压

妊娠中期eGFR与不良妊娠结局:妊娠期超滤过的临床意义

Midterm eGFR and Adverse Pregnancy Outcomes: The Clinical Significance of Gestational Hyperfiltration.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-06-13

该观察性队列研究纳入1931例单胎妊娠女性,分析妊娠中期eGFR与不良妊娠结局的关系。不良妊娠结局包括早产、低出生体重和子痫前期,共发生538例。中期eGFR与不良结局呈U型曲线,最佳范围为120-150 ml/min per 1.73 m2;无基线CKD者中,不良结局者超滤过现象更不明显。

要点

  • 妊娠中期eGFR与不良妊娠结局呈U型关系,最佳范围120-150 ml/min per 1.73 m2。
  • eGFR低于90 ml/min per 1.73 m2时不良结局风险显著升高(aOR 4.93)。
  • 无基线CKD者中,缺乏明显超滤过可能是不良妊娠结局的风险因素。

核心结论

  • 妊娠中期eGFR与不良妊娠结局呈U型曲线,最佳eGFR范围为120-150 ml/min per 1.73 m2。
  • 在无基线CKD的孕妇中,缺乏明显的妊娠期超滤过可能与不良妊娠结局相关。

研究设计与样本

  • 观察性队列研究,纳入2001至2015年韩国两家大学医院单胎妊娠且孕中期有血清肌酐检测的孕妇。
  • 排除肾功能明显受损或孕中期分娩者,最终分析1931例妊娠。
  • MRH以CKD-EPI法计算的最高eGFR表示,不良妊娠事件定义为早产(<37周)、低出生体重(<2.5 kg)和子痫前期的复合结局。

主要发现

  • 538例孕妇发生不良妊娠结局。
  • 以eGFR 120-150 ml/min per 1.73 m2为参照,eGFR≥150 ml/min per 1.73 m2的调整OR为1.97(95%CI 1.34-2.89,P<0.001)。
  • eGFR 90-120 ml/min per 1.73 m2的调整OR为1.57(95%CI 1.23-2.00,P<0.001)。
  • eGFR 60-90 ml/min per 1.73 m2的调整OR为4.93(95%CI 1.97-12.31,P<0.001)。
  • 在无基线CKD的孕妇中,发生不良妊娠结局者MRH程度较无不良结局者更低(P<0.001)。

临床怎么用

  • 临床可关注妊娠中期eGFR水平,尤其是低于90 ml/min per 1.73 m2或高于150 ml/min per 1.73 m2时。
  • 对于无基线CKD的孕妇,若缺乏明显的妊娠期超滤过(eGFR未明显升高),应警惕不良妊娠结局风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Although hemodynamic adaptation plays a crucial role in maintaining gestation, the clinical significance of midterm renal hyperfiltration (MRH) on pregnancy outcomes is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was an observational cohort study. Women with a singleton pregnancy and a serum creatinine measurement during their second trimester were followed at two university hospitals in Korea between 2001 and 2015. Those with substantial renal function impairment or who delivered during the second trimester were not considered. MRH was represented by the highest eGFR, which was calculated using the Chronic Kidney Disease Epidemiology Collaboration method. An adverse pregnancy event was defined by the composition of preterm birth (gestational age <37 weeks), low birth weight (<2.5 kg), and preeclampsia. RESULTS: Data from 1931 pregnancies were included. The relationship between midterm eGFR and adverse pregnancy outcomes, which occurred in 538 mothers, was defined by a nonlinear U-shaped curve. The adjusted odds ratio and associated 95% confidence interval (95% CI) of an adverse pregnancy outcome for eGFR levels below and above the reference level of 120-150 ml/min per 1.73 m2 were 1.97 (95% CI, 1.34 to 2.89; P<0.001) for ≥150 ml/min per 1.73 m2; 1.57 (95% CI, 1.23 to 2.00; P<0.001) for 90-120 ml/min per 1.73 m2; and 4.93 (95% CI, 1.97 to 12.31; P<0.001) for 60-90 ml/min per 1.73 m2. Moreover, among mothers without baseline CKD, women with adverse pregnancy outcomes had less prominent MRH than those without (P<0.001). CONCLUSIONS: We identified a unique U-shaped relationship between midterm eGFR and adverse pregnancy outcomes, and the optimal range of midterm eGFR levels was 120-150 ml/min per 1.73 m2. In those without evident functional renal impairment, the absence of prominent MRH might be a significant risk factor for poor pregnancy outcomes.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Park S, Lee SM, Park JS, et al. Midterm eGFR and Adverse Pregnancy Outcomes: The Clinical Significance of Gestational Hyperfiltration. Clin J Am Soc Nephrol. 2017. PMID: 28611078. doi:10.2215/CJN.12101116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。